Tacrolimus
Intervention4 papers2 findingsPubChem 445643ChEBI 61049MeSH D016559
- Humans2
- Animals1
Outcomes
2Mortality
downin humans1HR 0.18Moderate certainty
1 study
Mortality
downin humans1HR 0.18Moderate certainty
Tacrolimus decreases mortality in humans (HR 0.18, 95% CI 0.05-0.66, p = 0.009).
Humanscompared with cyclosporine in KTRs
Fracture incidence and mortality in kidney transplant recipients compared with waitlisted dialysis patients: A single-center retrospective analysis · Clinical nephrology · 8 Sep 2026
Graft survival
upin Papio1Very low certainty
1 study
Graft survival
upin Papio1Very low certainty
Tacrolimus improves graft survival in Papio (up to 675 days).
Animalswith anti-CD2, anti-CD154, and belataceptn = 7
Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation · Xenotransplantation · 1 Jan 2026
Funding
National Institute on AgingUS$915.2k1 grant since 2017